Para-aminobenzoic acid (PABA) used as a marker for completeness of 24 hour urine: effects of age and dosage scheduling

Eur J Clin Nutr. 2003 Jan;57(1):138-42. doi: 10.1038/sj.ejcn.1601505.

Abstract

Objective: To examine the age dependency of the urinary para-aminobenzoic acid (PABA) excretion, and if a delayed PABA excretion can be overcome by advancing intake schedule; and to examine the recovery of PABA in fractionated urinary samples collected during 24 h after single and repeated doses of PABA.

Design: Cross-over study with subjects randomized to start with recommended schedule of PABA administration (80 mg at 08:00, 12:00 and 18:00; PABA18) and then an advanced schedule (80 mg at 08:00, 12:00 and 15:00; PABA15) or vice versa. One subgroup of eight subjects collected individual urine specimens for 24 h after a morning dose of 80 mg of PABA, and another subgroup of 10 subjects collected individual urine specimens for 24 h after ingestion of 80 mg of PABA three times at mealtimes.

Subjects: Employees and relatives from the Danish Food Administration.

Setting: Ninety-nine healthy volunteers (61 females and 38 males) aged 30-91 y.

Results: Linear regressions for PABA15 and PABA18 demonstrate significantly less recovery with age (PABA15: r(2)=0.1784, P=0.0002; PABA18: r(2)=0.1273, P=0.0019). Linear regression of DeltaPABA (PABA15-PABA18) with age showed the best fit line to be horizontal (slope -0.0066, P=0.89; 95% CI -0.1046, 0.0915) and with a Y-intercept not significantly different from 0 (1.575; 95% CI -4.176, 7.326). In this population the lower limit for complete 24 h urine collection was 79.2%. After a single dosage of 80 mg PABA 70-85% was recovered after 8 h. Within 16 h after ingestion of 240 mg PABA at recommended hours the lowest acceptable recovery (78.1%) was reached.

Conclusion: There is a gradual decline of PABA recovery with age that cannot be overcome by advancing the dosage schedule. Because of a lower delimiting PABA recovery for the elderly, some 24 h collections in this age group will be rejected unjustly (false-negatives). Also, with the currently recommended dosage schedule (PABA taken with the main meals) the risk of false-positive 24 h urine collections prevails. With refinement of the PABA test procedure, ie employing a specific analytical method and age-dependent cut-off values, the test may achieve a higher specificity and sensitivity.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • 4-Aminobenzoic Acid / administration & dosage
  • 4-Aminobenzoic Acid / urine*
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Aging / physiology
  • Aging / urine*
  • Biomarkers / urine
  • Chromatography, High Pressure Liquid / methods
  • Cross-Over Studies
  • Drug Administration Schedule
  • False Negative Reactions
  • Female
  • Humans
  • Linear Models
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Sensitivity and Specificity
  • Time Factors

Substances

  • Biomarkers
  • 4-Aminobenzoic Acid